ArticleBMC cardiovascular disorders2026
Age- and sex-specific normative values for reticulocyte indices and their relation to early-stage CKM syndrome.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundReticulocyte-related indices reflect erythropoietic activity and red blood cell maturation and may provide insight into systemic metabolic and inflammatory states. Cardiovascular-kidney-metabolic (CKM) syndrome is a progressive systemic disorder driven by interacting metabolic, renal, and cardiovascular abnormalities. This study aimed to establish age- and sex-specific normative values for reticulocyte-related indices and to explore their cross-sectional associations with early-stage CKM syndrome.
methodsA total of 5,692 adults aged 20-80 years from the China National Health Survey were included in this cross-sectional study for the final analysis. The Lambda-Mu-Sigma method was used to generate age- and sex-specific smoothed percentiles for reticulocyte indices, including RET# (reticulocyte count), RET% (reticulocyte percentage), LFR (low fluorescence reticulocytes), MFR (medium fluorescence reticulocytes), HFR (high fluorescence reticulocytes), IRF (immature reticulocyte fraction), RET-HE (reticulocyte hemoglobin equivalent), and RPI (reticulocyte production index), with percentile estimates at P1, P5, P25, P50, P75, P95, and P99. Differences across early CKM stages were assessed using one-way analysis of variance, chi-square tests, and analysis of covariance. Receiver operating characteristic analysis was used to evaluate discriminative performance.
resultsReticulocyte-related indices showed significant sex-specific and age-specific variation, generally increasing in younger and middle-aged adults and then plateauing or declining in older adults. Several indices were associated with CKM stage progression. In particular, RET#, RET%, and RPI increased across CKM stages, whereas LFR decreased. ROC analysis showed that RET# provided good discrimination between CKM stage 0 and stages 1-2, with improved performance after adjustment for age and sex.
conclusionReticulocyte-related indices exhibit distinct age- and sex-specific distributions and are associated with early CKM stage status in this cross-sectional population. These findings provide normative reference data and suggest that reticulocyte indices may serve as exploratory indicators of systemic metabolic status, although prospective studies are needed to establish clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.